Schizophrenia, Bipolar Disorder, and the Psychosis Continuum
Awareness of differences between psychosis in schizophrenia and bipolar disorder and varying presentations in patients can assist providers with diagnosis and treatment.
Schizophrenia and Psychoses
SCHIZOPHRENIA AND PSYCHOSES
Featured Article
Latest News
Schizophrenia and Bipolar Disorder May Share Sleep-Circadian Rhythm Phenotypes
Patients with bipolar disorder experienced significant reductions in sleep efficiency, which was not the case in patients with schizophrenia, although effect sizes for bipolar disorder were smaller overall.
Scoring Analysis Detects Genetic Correlation Between Osteoporosis and Schizophrenia
Researchers explored the genetic correlation between schizophrenia and osteoporosis.
Decline in Treatment Effect, Increase in Placebo Response in Clinical Trials of Schizophrenia
The study confirmed a continuation of the trend for elevated placebo response and reduced treatment effect in clinical trials of schizophrenia medications.
First Generic Injection Version of Geodon Available for Schizophrenia
Dr. Reddy’s Laboratories announced the launch of Ziprasidone Mesylate for Injection, the generic equivalent of Geodon for Injection (Pfizer).
Cognitive Impairment, Irregular Neural Activity May Be a Signature of Negative Psychotic Symptoms
Together with cognitive impairment and eye movement abnormalities, diminished EEG response appears to form a neurobiological “fingerprint” for negative symptoms in psychosis.
Cannabis Use Disorder May Reduce Risk of Digestive Disorders in Schizophrenia
In patients with schizophrenia, cannabis use may be linked to elevated risk of all-cause mortality but decreased risk of mortality from digestive organ diseases.
Infections—a Risk Factor for Developing Substance-Induced Psychosis
Infections raised the risk for substance-induced psychosis, with the risk doubled for the first 2 years. The largest increase in risk was observed for hepatitis.
Patient Experiences With Antipsychotics Largely Negative, Survey Shows
Roughly two-thirds of patients categorized their experience with antipsychotics as more negative than positive and 34.9% endorsed an “extremely negative” experience.
Network Analysis Demonstrates Importance of Early Interventions for Schizophrenia
Connectivity was significantly higher in nonrecovered than recovered patients, and there were fewer connections in recovered patients compared with nonrecovered patients, indicating significant differences in network structure.
Reproducible Epigentic Signature for Schizophrenia May Explain Gene-Environment Interactions
Working memory is impaired in schizophrenia, and epigenetic mechanisms such as DNA methylation may contribute to illness risk.
Want to read more?
Please login or register first to view this content.
Next post in Schizophrenia and Psychoses
